ArticlePsychiatric services (Washington, D.C.)2026
Availability of Treatment for Alcohol and Opioid Use Disorders Among Accountable Care Organization Participants.
Article in Psychiatric services (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveThis study examined whether an organization's investment in opioid use disorder services complements or detracts from its capacity to provide alcohol use services.
methodsUsing data from the 2022 National Survey of Accountable Care Organizations (N=200 respondents to alcohol-related questions), the authors estimated the percentage of organizations participating in accountable care organization contracts that provided alcohol-related services (brief counseling or medications), either by direct provision or via referral. They tested whether organizations offering buprenorphine for opioid use disorder were more or less likely to offer alcohol-related services.
resultsMost respondents (81%) reported that their organization provided brief counseling directly, but less than half (45%) provided medications for alcohol use disorder directly. Respondents providing buprenorphine (62%) had higher rates of alcohol-related service provision.
conclusionsAlthough medications for alcohol use disorder were provided less frequently than buprenorphine, no evidence suggests that treatment services for opioid use disorder crowded out those for alcohol use disorder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.